Regulation of Aldo-keto Reductases in Human Diseases

The aldo-keto reductases (AKRs) are a superfamily of NAD(P)H-linked oxidoreductases, which reduce aldehydes and ketones to their respective primary and secondary alcohols. AKR enzymes are increasingly being recognized to play an important role in the transformation and detoxification of aldehydes an...

Full description

Bibliographic Details
Main Authors: Wei-Dong eChen, Yanqiao eZhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2012-03-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphar.2012.00035/full
_version_ 1818494723301572608
author Wei-Dong eChen
Yanqiao eZhang
author_facet Wei-Dong eChen
Yanqiao eZhang
author_sort Wei-Dong eChen
collection DOAJ
description The aldo-keto reductases (AKRs) are a superfamily of NAD(P)H-linked oxidoreductases, which reduce aldehydes and ketones to their respective primary and secondary alcohols. AKR enzymes are increasingly being recognized to play an important role in the transformation and detoxification of aldehydes and ketones generated endogenously and exogenously during drug detoxification and xenobiotic metabolism. Many transcription factors have been identified to regulate the expression of human AKR genes, which could have profound effects on the metabolism of endogenous mediators and detoxication of chemical carcinogens. This review summarizes the current knowledge of AKR regulation by transcription factors and other mediators in human diseases.
first_indexed 2024-12-10T18:10:16Z
format Article
id doaj.art-eb77b9873eb94539bc3332c3f48bc2ea
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-10T18:10:16Z
publishDate 2012-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-eb77b9873eb94539bc3332c3f48bc2ea2022-12-22T01:38:30ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122012-03-01310.3389/fphar.2012.0003520138Regulation of Aldo-keto Reductases in Human DiseasesWei-Dong eChen0Yanqiao eZhang1Northeast Ohio Medical UniversityNortheast Ohio Medical UniversityThe aldo-keto reductases (AKRs) are a superfamily of NAD(P)H-linked oxidoreductases, which reduce aldehydes and ketones to their respective primary and secondary alcohols. AKR enzymes are increasingly being recognized to play an important role in the transformation and detoxification of aldehydes and ketones generated endogenously and exogenously during drug detoxification and xenobiotic metabolism. Many transcription factors have been identified to regulate the expression of human AKR genes, which could have profound effects on the metabolism of endogenous mediators and detoxication of chemical carcinogens. This review summarizes the current knowledge of AKR regulation by transcription factors and other mediators in human diseases.http://journal.frontiersin.org/Journal/10.3389/fphar.2012.00035/fullregulationtranscription factorHuman Diseasealdo-keto reductaseresponse element
spellingShingle Wei-Dong eChen
Yanqiao eZhang
Regulation of Aldo-keto Reductases in Human Diseases
Frontiers in Pharmacology
regulation
transcription factor
Human Disease
aldo-keto reductase
response element
title Regulation of Aldo-keto Reductases in Human Diseases
title_full Regulation of Aldo-keto Reductases in Human Diseases
title_fullStr Regulation of Aldo-keto Reductases in Human Diseases
title_full_unstemmed Regulation of Aldo-keto Reductases in Human Diseases
title_short Regulation of Aldo-keto Reductases in Human Diseases
title_sort regulation of aldo keto reductases in human diseases
topic regulation
transcription factor
Human Disease
aldo-keto reductase
response element
url http://journal.frontiersin.org/Journal/10.3389/fphar.2012.00035/full
work_keys_str_mv AT weidongechen regulationofaldoketoreductasesinhumandiseases
AT yanqiaoezhang regulationofaldoketoreductasesinhumandiseases